| Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease BR Stockwell, JPF Angeli, H Bayir, AI Bush, M Conrad, SJ Dixon, S Fulda, ... Cell 171 (2), 273-285, 2017 | 5766 | 2017 |
| Label-free biomarker detection from whole blood E Stern, A Vacic, NK Rajan, JM Criscione, J Park, BR Ilic, DJ Mooney, ... Nature nanotechnology 5 (2), 138-142, 2010 | 671 | 2010 |
| Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy J Park, SH Wrzesinski, E Stern, M Look, J Criscione, R Ragheb, SM Jay, ... Nature materials 11 (10), 895-905, 2012 | 563 | 2012 |
| PEGylated PLGA nanoparticles for the improved delivery of doxorubicin J Park, PM Fong, J Lu, KS Russell, CJ Booth, WM Saltzman, TM Fahmy Nanomedicine in cancer, 575-596, 2017 | 453 | 2017 |
| Nanosystems for simultaneous imaging and drug delivery to T cells TM Fahmy, PM Fong, J Park, T Constable, WM Saltzman The AAPS journal 9, E171-E180, 2007 | 161 | 2007 |
| Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF) S Rittchen, A Boyd, A Burns, J Park, TM Fahmy, S Metcalfe, A Williams Biomaterials 56, 78-85, 2015 | 141 | 2015 |
| Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery J Park, W Gao, R Whiston, TB Strom, S Metcalfe, TM Fahmy Molecular pharmaceutics 8 (1), 143-152, 2011 | 138 | 2011 |
| Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells MD McHugh, J Park, R Uhrich, W Gao, DA Horwitz, TM Fahmy Biomaterials 59, 172-181, 2015 | 136 | 2015 |
| Cell stimulation with optically manipulated microsources H Kress, JG Park, CO Mejean, JD Forster, J Park, SS Walse, Y Zhang, ... Nature methods 6 (12), 905-909, 2009 | 112 | 2009 |
| Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates J Park, T Mattessich, SM Jay, A Agawu, WM Saltzman, TM Fahmy Journal of controlled release 156 (1), 109-115, 2011 | 105 | 2011 |
| Nanomed.: Nanotechnol HK Patra, S Banerjee, U Chaudhuri, P Lahiri, AK Dasgupta Biol. Med 3, 111-119, 2007 | 42 | 2007 |
| Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles B Corradetti, P Freile, S Pells, P Bagnaninchi, J Park, TM Fahmy, ... Biomaterials 33 (28), 6634-6643, 2012 | 35 | 2012 |
| Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 9,610,250, 2017 | 18 | 2017 |
| Biodegradable nanoparticles for drug delivery J Park, TM Fahmy Handbook of Nanophysics: Nanomedicine and Nanorobotics, 1-14, 2010 | 9 | 2010 |
| Development of PTH eluting microspheres for the treatment of hypoparathyroidism P Fong, A Goyal, M Brennan, J Park, L Moss, WM Saltzman, CK Breuer Journal of Surgical Research 143 (2), 195-199, 2007 | 8 | 2007 |
| Heart valves PM Fong, J Park, CK Breuer Principles of Tissue Engineering, Third Edition, 585-601, 2007 | 5 | 2007 |
| Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 10,603,276, 2020 | 4 | 2020 |
| Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent 11,173,119, 2021 | 2 | 2021 |
| Nanolipogel vehicles for controlled delivery of different pharmaceutical agents TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski US Patent App. 17/399,544, 2022 | | 2022 |
| PEGylated PLGA Nanoparticles for the Improved Delivery of Doxorubicin J Park, PM Fong, J Lu, KS Russell, CJ Booth, WM Saltzman, TM Fahmy Nanomedicine in Cancer, 575-596, 2017 | | 2017 |
Tarek M. FahmyYale UniversityDirección de correo verificada de yale.edu